| First author | Year | Patients | Age | Gender | Rheumatic disease | Anti-TNF administered |
|---|---|---|---|---|---|---|
Jeudy |
2007 |
1 |
59 |
F |
RA |
Infliximab |
Spillane |
2007 |
1 |
40 |
F |
RA |
Adalimumab |
Sheth |
2007 |
1 |
51 |
F |
RA |
Adalimumab |
Burmester |
2007 |
1 |
NA |
NA |
RA |
Adalimumab |
| Pataka | 2006 |
1 |
75 |
M |
AS |
Infliximab 5 |
| Comby | 2006 |
1 |
NE |
M |
RA |
Infliximab |
| Van Rijthoven | 2006 |
1 |
56 |
F |
RA |
Adalimumab |
| Kang | 2006 |
1 |
55 |
F |
RA |
Etanercept |
| Schiff | 2006 |
13 |
NE |
NE |
13RA |
13Adalimumab |
| Chadha | 2006 |
1 |
34 |
F |
RA |
Infliximab |
| Schneider | 2006 |
1 |
51 |
F |
RA |
Infliximab |
| Perez-Garcia | 2006 |
1 |
65 |
F |
AS |
Infliximab |
| Pallotta | 2006 |
1 |
50 |
F |
PsA |
Infliximab |
| Benucci | 2005 |
1 |
45 |
M |
RA |
Infliximab 3 |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
F |
PsA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
F |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
M |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
M |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Infliximab |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Etanercept |
| De Bandt | 2005 |
1 |
NE |
NE |
RA |
Infliximab |
| Richez | 2005 |
1 |
55 |
F |
RA |
Infliximab |
| High | 2005 |
1 |
80 |
F |
RA |
Infliximab |
| Mor | 2005 |
1 |
22 |
F |
JRA |
Etanercept |
| Flendrie | 2005 |
1 |
58 |
F |
RA |
Infliximab |
| Nancey | 2005 |
1 |
NE |
NE |
CD |
Infliximab |
| Elkayam | 2005 |
2 |
NE |
NE |
2RA |
2Infliximab |
| Roux | 2004 |
1 |
43 |
F |
RA |
Etanercept |
| Novak | 2004 |
1 |
53 |
F |
RA |
Infliximab 3 |
| Stratigos | 2004 |
1 |
53 |
F |
RA |
Infliximab |
| Colombel | 2004 |
3 |
NE |
NE |
3CD |
3Infliximab 5 |
| Stokes | 2004 |
1 |
30 |
F |
RA |
Etanercept |
| Stokes | 2004 |
1 |
52 |
F |
RA |
Adalimumab |
| Christopher-Stine | 2003 |
1 |
44 |
F |
MTCD |
Etanercept |
| Christopher-Stine | 2003 |
1 |
38 |
M |
MTCD |
Infliximab |
| Sarzi-Puttini | 2003 |
1 |
18 |
M |
CD |
Infliximab 5 |
| Klapman | 2003 |
1 |
45 |
F |
CD |
Infliximab |
| Swale | 2003 |
1 |
55 |
F |
RA |
Etanercept |
| Carlson | 2003 |
1 |
45 |
F |
RA |
Etanercept |
| Favalli | 2002 |
1 |
69 |
F |
RA |
Infliximab 3-5 |
| Ali | 2002 |
1 |
51 |
F |
CD |
Infliximab 5 |
| Cairns | 2002 |
1 |
51 |
F |
RA |
Etanercept |
| Shakoor | 2002 |
1 |
72 |
F |
RA |
Etanercept |
| Shakoor | 2002 |
1 |
47 |
F |
RA |
Etanercept |
| Shakoor | 2002 |
1 |
39 |
F |
RA |
Etanercept |
| Shakoor | 2002 |
1 |
50 |
F |
RA |
Etanercept |
| Mohan | 2002 |
13 |
49 |
11F/2M |
13RA |
13Etanercept |
| Bleumink | 2001 |
1 |
54 |
F |
RA |
Etanercept |
| Bleumink | 2001 |
1 |
50 |
F |
RA |
Etanercept |
| Bleumink | 2001 |
1 |
NE |
F |
RA |
Etanercept |
| Bleumink | 2001 |
1 |
65 |
M |
RA |
Etanercept |
| Charles | 2000 |
1 |
37 |
F |
RA |
Infliximab 3 |
| Brion | 1999 |
1 |
78 |
F |
RA |
Etanercept |
| Rutgeerts | 1999 |
1 |
NE |
NE |
CD |
Infliximab 5 |